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Abstract
The field of precision medicine aims to tailor treatment based on patient-
specific factors in a reproducible way. To this end, estimating an optimal in-
dividualized treatment regime (ITR) that recommends treatment decisions
based on patient characteristics to maximize the mean of a pre-specified
outcome is of particular interest. Several methods have been proposed for
estimating an optimal ITR from clinical trial data in the parallel group set-
ting where each subject is randomized to a single intervention. However,
little work has been done in the area of estimating the optimal ITR from
crossover study designs. Such designs naturally lend themselves to precision
medicine, because they allow for observing the response to multiple treat-
ments for each patient. In this paper, we introduce a method for estimating
the optimal ITR using data from a 2 × 2 crossover study with or without
carryover effects. The proposed method is similar to policy search methods
such as outcome weighted learning (OWL); however, we take advantage of
the crossover design by using the difference in responses under each treat-
ment as the observed reward. We establish Fisher and global consistency,
present numerical experiments, and analyze data from a feeding trial to
demonstrate the improved performance of the proposed method compared
to standard methods for a parallel study design.
Keywords: Crossover design; Individualized treatment regime; Machine learning;
Outcome weighted learning; Personalized medicine; Precision medicine
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1 Introduction
Personalized medicine is the practice of tailoring treatment to account for patient
heterogeneity (Chakraborty and Murphy, 2014). Physicians and other health care
providers have practiced personalized medicine by adjusting doses or prescriptions
based on a patient’s medical history or demographics for centuries (Ashley, 2015;
Zhao and Zeng, 2013). Precision medicine is an emerging field that aims to support
personalized medicine decisions with reproducible research (Collins and Varmus,
2015). Such research is imperative, particularly when diseases are expressed with
great heterogeneity across patients. A topic of interest in precision medicine is the
individualized treatment regime (ITR): a set of decision rules for one or more deci-
sion time points that can be used to assign patients to treatment tailored by their
patient-specifict factors (Lavori and Dawson, 2014; Moodie et al., 2007; Petersen
et al., 2007). One objective in precision medicine is to estimate the optimal ITR,
or the ITR that maximizes the mean of some desirable outcome (Kosorok and
Moodie, 2015; Laber et al., 2014). Crossover clinical trials are uniquely suited to
precision medicine, because they allow for observing responses to multiple treat-
ments for each patient. This paper introduces a method to estimate optimal ITRs
using data from a crossover study by extending generalized outcome weighted
learning (GOWL) (Chen et al., 2018) to deal with correlated outcomes.
In a crossover study, patients are randomized to a sequence of treatments rather
than a single treatment. Thus, multiple outcomes are observed, one per subject
from each treatment period, and each subject acts as his or her own control for re-
duced between-subject variability (Machin and Fayers, 2010; Turner, 2010; Wellek
and Blettner, 2012). Therefore, crossover designs naturally lend themselves to pre-
cision medicine; estimating the optimal ITR from a crossover design can utilize all
counterfactual outcomes. In contrast, estimating the optimal ITR from traditional
parallel group designs, where patients are assigned to a single treatment, can only
utilize the subset of counterfactual outcomes that are observed.
There have been many developments in machine learning methods for answer-
ing precision medicine questions from parallel study designs. For example, Qian
and Murphy (2011) indirectly estimate the decision rule using L1 penalized least
squares; Zhang et al. (2012a) maximize a doubly robust augmented inverse prob-
ability weighted estimator for the population mean outcome; Athey and Wager
(2017) maximize a doubly robust score that may take into account instrumental
variables; Kallus (2018) employs a weighting algorithm similar to inverse proba-
bility weighting but minimize the worst case mean square error; Laber and Zhao
(2015) propose the use of decision trees, which prove to be both flexible and easily
interpretable; Zhao et al. (2012), Zhang et al. (2012b), Zhou et al. (2017), and
Chen et al. (2018) directly estimate the decision rule by viewing the problem from
a weighted classification standpoint.
1
However, little work has been done to develop precision medicine methods that
handle correlated observations in the single-stage decision setting such as those
that arise from crossover designs. Kulasekera and Siriwardhana (2018) propose
a weighted ranking algorithm to estimate a decision rule that maximizes either
the expected outcome or the probability of selecting the best treatment, but they
assume that there are no carryover effects present. Because the intended effect of
the washout period can be difficult to achieve in practice (Wellek and Blettner,
2012), it is imperative that methods for crossover designs can be applied when
carryover effects are present. In this paper, we show that the difference in response
to two treatments from a 2 × 2 crossover trial can be used as the reward in the
generalized outcome weighted learning (GOWL) objective function to estimate
an optimal ITR. We introduce a plug-in estimator that can be used with the
proposed method to account for carryover effects. Additionally, we show that
using a crossover design with the proposed method results in improvements in
misclassification rate and estimated value when compared to standard methods
for a parallel design at the same sample size.
As a clinical example, consider nutritional recommendations surrounding the
intake of dietary fiber for the purpose of weight loss. Although increased fiber
is recommended across the population for a myriad of health benefits (Anderson
et al., 1994, 2009; Marlett et al., 2002; US Department of Agriculture, 2010), evi-
dence of the impact of the consumption of dietary fiber for improved satiety and
reduction in body weight is mixed (Halliday et al., 2018; Slavin, 2005). Hetero-
geneity in response to dietary fiber may be leveraged to develop targeted fiber
interventions to promote feelings of satiety. We use data from a crossover study in
which Hispanic and African American adolescents who are overweight and obese
were fed breakfast and lunch under a typical western high sugar diet and a high
fiber diet. From these data, we estimate a decision rule with which clinical care
providers can input patient characteristics, including demographics and clinical
measures, and receive a recommendation to maximize the change in measures of
perceived satiety from before breakfast to after lunch. This type of analysis could
be useful in identifying a subgroup of at-risk adolescents for which targeting spe-
cific dietary recommendations is expected to lead to an increase in patient-reported
satiety, helping to decrease caloric intake in a population with great clinical need
for effective weight loss strategies.
The rest of this paper is organized as follows. In Section 2, we review outcome
weighted learning (OWL) (Zhao et al., 2012) and present the proposed method
for estimating an optimal ITR from a crossover study regardless of the presence
of carryover effects. Section 3 establishes Fisher and global consistency. Section
4 demonstrates the performance of the proposed method in simulation studies,
with results on misclassification rate and estimated value. Section 5 reports on
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the analysis of data from a feeding trial with overweight and obese Latino and
African American adolescents, and we conclude with a discussion in Section 6.
2 Methodology
In this section, we provide a brief overview of existing methods for estimating the
optimal ITR using weighted classification. We then provide the justification and
means to implement our proposed method, which we will from here refer to as
“crossover GOWL.”
2.1 Existing Methods
Consider a parallel, two-arm clinical trial in which we have i.i.d. observations
(X i, Ai, Yi) for i = 1, . . . , n, where A ∈ A = {−1, 1} is binary treatment assign-
ment, X ∈ X is a p-dimensional vector of covariates, and Y ∈ R is a reward,
bounded by M0 < ∞, for which greater values are desired. Assume that Y is of
the form
Y = µ(X) + Ac(X) + ,
where µ(X) is the main effect of the covariates, c(X) is the treatment-covariate
interaction, and  has mean 0 and variance σ2 . Denote Y
∗(a) as the counterfactual
outcome under treatment a. We then make three causal assumptions (Rubin, 1978)
to connect the counterfactual outcomes to the observed data: P (A = a|X) > 0
with probability 1, {Y ∗(1), Y ∗(−1)} ⊥ A|X, and Y = Y ∗(a). These are known as
positivity, conditional exchangeability, and consistency, respectively.
An ITR, D, comes from the set of all functions D that map the covariate space
X to the treatment spaceA. Our objective is to estimate the optimal ITR, denoted
D0, which maximizes the value function (Qian and Murphy, 2011),
V(D) = E
[
Y 1{A = D(X)}
P (A|X)
]
, (1)
where P (A|X) = Pr(A = a|X = x) is the propensity score for treatment. Equiv-
alently, D0 may be defined as
D0 = argmin
D∈D
E
[
Y 1{A 6= D(X)}
P (A|X)
]
. (2)
Zhao et al. (2012) propose OWL to solve this problem: each misclassified
observation is weighted by its observed outcome, Y , and the hinge loss is used to
bring the problem into the support vector machine framework (Cortes and Vapnik,
1995). Unfortunately, OWL assumes Y is nonnegative; when negative values are
observed, OWL shifts all outcomes to be nonnegative, since (2) is invariant to
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such a transformation. The objective function in OWL, however, does not have
this property. Therefore, the estimated decision function in OWL depends on the
chosen shift in the outcomes. Chen et al. (2018) propose GOWL, an extension of
OWL, which handles negative rewards by modifying the hinge loss to be piecewise
and weighting the misclassified observations by |Y |. With GOWL, there is no need
to shift rewards.
However, neither Zhao et al. (2012) nor Chen et al. (2018) considered corre-
lated outcomes, such as those that arise from a crossover design setting. We now
introduce crossover GOWL, a method that combines the observed treatment re-
sponse difference with GOWL to estimate the optimal ITR from 2 × 2 crossover
data.
2.2 Crossover Generalized Outcome Weighted Learning
In a crossover design, patients are randomly assigned to a sequence of treatments
rather than a single treatment. For the 2 × 2 design, patients are randomized to
receive either the (−1, 1) or the (1,−1) sequence, with some prespecified washout
period between treatments. The washout period is a break between treatments
which serves to remove any carryover effects, or residual effects remaining from
a previous treatment at the start of the next treatment. Keeping most of the
notation from before, we now introduce sequential treatments and outcomes Ak
and Yk for periods k = 1, 2, respectively, i.e., Yk is the observed outcome after
receiving treatment Ak in period k. Furthermore, we assume the model
Yk = µ(X) + Akc(X) + δA1(X) 1{k = 2}+ k
where  = (1, 2)
> has mean 0 and a positive definite covariance matrix, Σ, and
δA1(X) is the carryover effect which may depend on A1 and X. Note that in
a 2 × 2 crossover study, the period effects, or temporal effects, are nonseparable
from the carryover effects (Fleiss, 1989), so δA1(X) encompasses both period and
carryover effects.
Let R = Y1 − [Y2 − δA1(X)]. Given the observed data (X, A1, Y ), we propose
the following as a substitute for the value function to be maximized:
E
[
R
P (A1|X)1{A1 = D(X)}
]
, (3)
where P (A1|X) is the probability of being assigned to the sequence (A1,−A1)
conditional on X. Under Lemma 2.1, maximizing (3) is equivalent to maximizing
(1); the proof is left to Appendix C.
Lemma 2.1. Under the given assumptions,
D0 = argmin
D∈D
E
[
R
P (A1|X)1{A1 6= D(X)}
]
.
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Following (3), we use an approach similar to GOWL but weight misclassified
observations by the treatment response difference, and we minimize the objective
function (4) for f in F , a class of functions, e.g., a reproducing kernel Hilbert
space. Let ψ(u, v) = max{1 − sign(u)v, 0}, λn be a tuning parameter, and ||f ||
be the L2 norm of f . For details on solving the minimization problem in (4), we
defer to Chen et al. (2018) and Kimeldorf and Wahba (1970).
argmin
f∈F
1
n
n∑
i=1
|Ri|
P (Ai,1|X i)ψ{Ri, Ai,1f(X i)}+ λn||f ||
2, (4)
In practice, the true value of δA1(X) is unknown. In traditional analyses, we
are concerned with testing the null hypothesis that δ−1(X) = δ1(X). Here, we are
instead interested in whether or not either treatment has a nonzero carryover effect.
Investigators may determine whether carryover effects are present any number of
ways, including two-sample t-tests for the null hypotheses H0,1: E[δ1(X)] = 0 and
H0,−1: E[δ−1(X)] = 0 by comparing mean responses to each treatment at each
time point. An estimator for δA1(X), denoted δ̂A1(X), can be computed using
Algorithm 1.
Algorithm 1: Estimating δA1(X)
1 Estimate g(x, a1) = E[Y1|X = x, A1 = a1] by regressing Y1 on X and
A1.
2 Set Ŷ2 = ĝ(X, A2).
3 Estimate δA1(X) by regressing Y2 − Ŷ2 on X and A1.
In short, one model is fit to predict what would have been observed in period 2
in the absence of carryover effects, and another model is fit to predict the residual
from the first model. While any regression technique may be used here, we use
reinforcement learning trees (RLT) in our implementation. RLT is a nonparametric
tree-based machine learning method that considers future splits or branches in the
model when determining the best split at any node (Zhu et al., 2015).
We can now correct the observed reward with the estimated carryover effects.
Letting R̂ = Y1 −
[
Y2 − δ̂Ai,1(X)
]
, the estimated decision function is
f̂ ∗n = argmin
f∈F
1
n
n∑
i=1
|R̂i|
P (Ai,1|X i)ψ
{
R̂i, Ai,1f(X i)
}
+ λn||f ||2, (5)
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and our proposed estimator of the optimal ITR is D̂∗(X) = sign
{
f̂ ∗n(X)
}
, where
D∗ = argmax
D∈D
E
[ |R|
P (A1|X)ψ{R,A1f(X)}
]
.
3 Theoretical Results
In this section, we establish both Fisher and global consistency. First, define
the risk under 0-1 loss to be R(f) = E[Y 1{A 6= sign[f(X)]}/P (A|X)]. The risk
under the modified loss function with the reward defined as the treatment response
difference is then
Rψ(f) = E
[
|R̂|
P (A1|X)ψ
{
R̂, A1f(X)
}]
.
Let f ∗(X) = argminf∈F Rψ(f), so that the corresponding ITR under the modi-
fied loss for the treatment response difference is D∗(X) = sign{f ∗(X)}. Under
Theorem 1, Fisher consistency for D∗(X) is derived.
Theorem 3.1. Under the given assumptions, D∗(X) = D0(X).
Consider that F = {k(·,x) : x ∈ X} for some kernel function k, and let F be
the closure of F . Define f0 to be the minimizer over all functions f for R(f), and
define f ∗0 to be the same for Rψ(f).
Theorem 3.2. Let λn > 0 be a sequence such that λn → 0 and λnn → ∞ with
probability going to 1 as n→∞. Assume ∃M1 <∞ such that P
(
|δ̂A1(X)| < M1
)
→
1 as n → ∞ and |δA1(X)| < M1 almost surely. If P
[
1{sign[R̂] 6= sign[R]}
]
=
oP (λn), then, for any distribution P of (X, A1,Y ), limn→∞Rψ(f̂ ∗n) →P Rψ (f ∗).
Furthermore, if f ∗0 ∈ F ,
lim
n→∞
R(f̂ ∗n)→P R (f0) .
Derivation of Theorems 1 and 2 may be found in Appendix C.
4 Simulation Studies
To illustrate the benefits of using crossover GOWL, we present simulation stud-
ies with comparisons to standard methods used in parallel group clinical trials.
Simulated data sets were generated as follows. The covariates, X1, . . . ,X50, are
6
i.i.d. variables drawn from a U(−1, 1) distribution. Subjects were randomized
to treatment −1 or 1 for the parallel design or to sequence (−1, 1) or (1,−1)
for the crossover design with equal probability. The response for the parallel
design, Y, is normally distributed with a mean of µ(X) + c(X)A and a vari-
ance of 1. For the crossover design, responses were simulated per the model
Yk = µ(X) + Akc(X) + δA1(X) 1{k = 2} + k, for k = 1, 2, where  was drawn
from a multivariate normal distribution with mean 0, Var[1] = Var[2] = 1, and
Cov[1, 2] = 0.5. µ(X) was fixed to be 1 + X1 + 2X2 + 0.5X3 + X4 for all
simulation scenarios. Table 1 describes choices of c(X) and δA1(X) defining four
scenarios.
Table 1: The interactive and carryover effects for the five simulation scenarios.
Scenario c(X) δ−1(X) δ1(X)
1 1.12(0.3−X1 −X2) 0 0
2 1.15(X1 − 1.25X22 ) 0 0
3 1.12(0.3−X1 −X2)
∣∣∣µ(X)+c(X)4 ∣∣∣ ∣∣∣µ(X)−c(X)2 ∣∣∣
4 1.15(X1 − 1.25X22 ) 0.4X21 + 0.3X2 1− 2X1 −X22
Scenarios 1 and 3 are linear in X, whereas Scenarios 2 and 4 are nonlinear.
Note that scenario pairs (1, 3) and (2, 4) are similar, but Scenarios 3 and 4 in-
clude carryover effects. The optimal ITR was estimated via crossover GOWL,
using a Gaussian kernel. The penalty parameter, λn, and the Gaussian kernel
bandwidth parameter, σn, were selected using 5-fold cross-validation on the grids
{0.1, 0.5, 1, 5, 10, 50, 100, 500}/n and (0.1, 0.2, . . . , 5.0), respectively. In scenarios
where carryover effects are present, RLT (Zhu et al., 2015) was used to fit both
models to estimate δ̂A1(X) using Algorithm 1.
A testing data set of size ntest = 10, 000 was generated similarly with period
1 data only. The misclassification rate, or Pntest1
{
D̂∗(X) 6= D0(X)
}
, of the esti-
mated ITR applied to the testing set was calculated, where Pntest is the empirical
mean in the test set. We also calculated the estimated value of the estimated ITR,
V̂
(
D̂∗
)
(Qian and Murphy, 2011), where
V̂(D) = Pntest [Y 1{A = D(X)}/P (A1|X)]
Pntest [1{A = D(X}/P (A1|X)]
. (6)
Note that P (A1|X) = 0.5 is constant here. The estimated value is the average
reward observed under the estimated optimal ITR when applied to the testing
set. Figure 3 in Appendix A displays the mean square error from estimating the
carryover effects with RLT for Scenarios 3 and 4.
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Simulations were repeated 1,000 times at training set sample sizes of 30, 75, 150,
300, and 600. Comparisons to various methods in the parallel setting at the same
sample size are presented in Figures 1 and 2. These methods include OWL, GOWL,
and ridge regression. For OWL and GOWL, a Gaussian kernel was used, and the
aforementioned grids for λn and σn are considered in 5-fold cross-validation. For
ridge regression, the model includes all covariates and treatment-covariate inter-
actions without any higher order terms or between-covariate interactions. 5-fold
cross-validation was used to determine a value for the the ridge penalty parameter,
where the same values for λn in the OWL methods are considered. All simulations
were performed with R version 3.4.3 (R Core Team, 2017). RLT was implemented
with the RLT package, version 3.2.1 (Zhu, 2017), and all OWL methods were im-
plemented with the DynTxRegime package, version 3.2 (Holloway et al., 2018).
While the DynTxRegime package does not currently support GOWL, the inputs
for OWL can be recoded to implement GOWL. Ridge regression was carried out
with the glmnet package (Friedman et al., 2010).
Figure 1 displays the average misclassification rates across all sample sizes,
methods, and scenarios. Figure 2 displays the mean square error of the esti-
mated value from the true value, i.e., Pntest
{[
V̂
(
D̂∗
)
− V̂ (D0)
]2}
from period
1 data. On average, crossover GOWL yields lower misclassification rates and
higher estimated values at smaller sample sizes across all scenarios. Crossover
GOWL shows marked improvement in both misclassification and estimated value
for small n. When n is large, ridge regression yields competitive results with that
from crossover GOWL, but crossover GOWL still appears to have marginal gains.
Although GOWL in the parallel setting does not perform as well as OWL in any
of the presented scenarios, Chen et al. (2018) discuss scenarios where improve-
ments in misclassification and estimated value are observed when using GOWL as
opposed to OWL.
5 FAME Feeding Trial Data Analysis
We present the application of crossover GOWL to data from the Food, Adolescents,
Mood and Exercise (FAME) crossover feeding trial, conducted at the University
of Southern California (USC) (O’Reilly et al., 2015). The FAME trial included
African American and Latino adolescents who were overweight or obese. African
American and Latino adolescents are disproportionately affected by overweight
and obesity outcomes compared to their non-Hispanic counterparts (Ogden et al.,
2014; O’Reilly et al., 2015; Taveras et al., 2013). Dietary intake is a major modi-
fiable risk factor and represents a key intervention point in improving weight loss
(Bleich et al., 2017; Kipping et al., 2008). One promising approach is to modify di-
etary components to improve satiety to indirectly reduce caloric intake (Anderson
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Figure 1: Mean missclassification rate of 1,000 simulations for estimating the opti-
mal ITR, applied to a testing set of size 10,000 for each of 4 simulation scenarios.
et al., 2009). In epidemiologic studies of adults in the US, fiber intake is inversely
associated with body weight and body fat (Slavin, 2005), even after adjusting for
confounding factors such as dietary fat intake. However, results from intervention
studies are mixed: increased dietary fiber intake has been shown to have varied
effects on body weight among adults who are overweight or obese, with limited
research in pediatric or adolescent populations (Ro¨ssner et al., 1987; Ryttig et al.,
1989; Slavin, 2005; Thompson et al., 2005; Tucker and Thomas, 2009). Given the
heterogeneity in the effects of dietary fiber intake on body weight, it is essential
to identify the subgroups of overweight and obese adolescents who may benefit
from tailored clinical advice to increase fiber intake. We estimate a decision rule
to identify a subgroup of adolescents who are overweight or obese that experiences
larger increases in patient-reported satiety from a high fiber diet as opposed to the
more common high sugar diet.
This study was conducted at the USC Health Sciences campus in Los Angeles,
California from 2008 to 2011. Eighty-six Latino and African American adolescents
(ages 14 to 17 years of age) who were overweight or obese (BMI percentile > 85%)
were recruited. Race was self-reported, and subjects were included if all four
9
Figure 2: Mean square error of the estimated value compared to the true value
from 1,000 simulations for estimating the optimal ITR, applied to a testing set of
size 10,000 for each of 4 simulation scenarios.
grandparents were Latino or African American. Subjects were excluded if they
had type 2 diabetes, were in a weight loss program within the past 6 months, or
used medications that influenced insulin or body composition. Informed written
parental consent and participant assent were acquired before all testing procedures.
The Institutional Review Board of USC approved all study procedures.
Participants received either a high sugar/low fiber (HSLF) meal plan or a
high fiber/low sugar (HFLS) meal plan for breakfast and lunch on two separate
visit days. Participants were randomized with equal probability to receive the
HSLF/HFLS or HFLS/HSLF sequence with a minimum 2 week washout period
between visits. The meals were isocaloric and matched for macronutrients except
sugar and fiber content. Participants initially attended a baseline visit at the Clin-
ical Trials Unit at the USC University Hospital where insulin sensitivity, Tanner
stage via examination by a medical professional, BMI percentile for age, sex, eth-
nicity, waist circumference, and hemoglobin A1c (HbA1c) were collected. Insulin
sensitivity was assessed via a frequently sampled intravenous glucose tolerance test
(FSIVGTT) and calculated using the minimal model (Bergman et al., 1979; Yang
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et al., 1987). At the subsequent test meal visits, participants received either a
HSLF or HFLS breakfast after a 10 hour overnight fast. At noon, the participants
received the same meal condition for lunch. Participants rated their hunger and
fullness via a 100 mm-visual analog scale (VAS) prior to breakfast and 45 minutes
after the start of lunch (300 minutes after breakfast). Participants were provided
with age appropriate activities between meals (e.g., video games, crafts, books,
etc.).
The satiety outcomes are formally defined as the negative change in hunger,
since lower values of hunger are desired, and the observed change in fullness be-
tween 8:00 AM and 1:00 PM (before breakfast and after lunch). Due to the nature
of the outcomes, the required 10 hour overnight fast, and the implemented min-
imum 2 week washout period, we assumed no carryover effects were present. Of
the 86 subjects who completed the study, 20 were removed for missing outcomes,
and 1 was removed for missing insulin sensitivity. Participants that did not return
within 5 weeks were also removed (n = 54). We compared crossover GOWL with
OWL, GOWL, and ridge regression using data from period 1 only. Methods were
implemented as described in Section 4. 5-fold cross-validated value estimates were
obtained, but rather than using Equation (6) which uses only period 1 data, the
value for each observation i = 1, . . . , nm in the mth fold’s testing set was computed
as Yi,11
{
A1 = D̂0(X)
}
+Yi,21
{
A2 = D̂0(X)
}
where nm is the size of the mth fold
for m = 1, . . . , 5. Although OWL, GOWL, and ridge regression were trained on
period 1 data, data from both periods were used to improve accuracy in the value
estimate because the testing set size for each fold is quite small.
Resulting estimated values, averaged across folds, are presented in Table 2
along with the mean outcome observed from period 1. For both outcomes, all
methods show improvement in the estimated value in comparison to randomiza-
tion, but crossover GOWL yields the highest improvement. For self-reported full-
ness, crossover GOWL also yields the smallest standard deviation. When training
crossover GOWL on the full dataset, 92% (51%) of participants are assigned to the
HFLS to maximize the change in fullness (hunger). The distribution of features
across the groups assigned to HFLS and HSLF from crossover GOWL for both
outcomes are presented in Figure 4 in Appendix B. Dietary fiber is recommended
to improve overall health in the general population (Marlett et al., 2002); how-
ever, the estimated ITRs from hunger and fullness may inform the development of
tailored dietary intake advice for subgroups of at-risk adolescents.
6 Discussion
Precision medicine is an emerging field with rapid developments in analytical meth-
ods; however, these advancements typically revolve around parallel designs. This
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Table 2: Mean (sd) 5-fold cross-validated estimated values for feeding trial data
compared with the observed value from period 1.
Outcome
Fullness Hunger
Ridge 3.00 (4.53) 5.60 (8.15)
OWL 3.07 (3.88) 5.45 (7.42)
GOWL 3.85 (4.97) 8.29 (7.93)
Crossover GOWL 6.39 (3.57) 10.50 (8.36)
Observed 0.96 4.66
paper proposes the combined use of crossover designs and generalized outcome
weighted learning for the purpose of estimating optimal ITRs. The proposed
method addresses a key gap in the literature; little to no work has been done
to better involve crossover designs in precision medicine, despite how naturally
crossover studies lend themselves to the field. Kulasekera and Siriwardhana (2018)
propose a ranking method to estimate the optimal ITR from a crossover study but
provide no recommendations on how to deal with carryover effects. In contrast,
crossover GOWL is able to handle such effects. Furthermore, regardless of the
presence of carryover effects, the proposed method shows improvements in the
estimated value and misclassification rate, especially at the smaller sample sizes
typical of crossover designs compared to standard methods with the parallel group
design.
An alternative to GOWL that has been developed is residual weighted learn-
ing (RWL) (Zhou et al., 2017). RWL is an extension of OWL that weights the
misclassification error by residuals from a model fit to the outcome instead of the
observed rewards themselves. Unlike GOWL, RWL uses a non-convex loss function
that does not guarantee global minimization (Tao et al., 2005). In the proposed
method, there is no need to include residuals in the weight, because the residu-
als would cancel when taking the difference between responses to each treatment.
Thus, the proposed method avoids specifying a model for the main effect of the
covariates.
We note that when the distribution of A˜1 = sign{R}A1 is poorly allocated,
the cross-validation mechanism for estimating λn and σ
2
n may fail. If there is prior
knowledge on the distribution of sign{R}, investigators could adjust randomization
probabilities when assigning patients to treatment sequences accordingly. Other-
wise, it is possible for a training set to not observe at least one A˜1 = 1 or A˜1 = −1.
Lastly, there may be low power in testing H0 : E[δA1(X)] = 0 at smaller sample
sizes.
Several extensions of estimating the optimal ITR from crossover data are yet
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to be explored. For example, only the 2 × 2 design was studied in this paper.
For larger design schemes, the proposed method could be implemented in a series
of binary classifiers as in Dietterich and Bakiri (1994). Alternatively, one could
expand crossover GOWL to multi-category classification. There have been several
developments in multi-category SVM (Lee et al., 2004; Zhu et al., 2004). More
recently, Liang et al. (2018) propose an outcome weighted deep learning method
to estimate the optimal ITR for multiple treatments. Another possible extension
is to consider the residual from modeling the treatment response difference as the
observed reward. Fu et al. (2016) and Zhou et al. (2017) have seen favorable re-
sults using residual weights, but further improvements may come from using the
residuals in outcome weighted learning with the piece-wise hinge loss from GOWL.
Finally, the proposed method could be improved upon with methods for variable
selection. For example, the L1 penalty could be imposed during optimization to
simultaneously restrict model complexity and perform variable selection as sug-
gested by Chen et al. (2018), Song et al. (2015), Xu et al. (2015), and Zhou et al.
(2017).
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Appendix
Appendix A
The reinforcement learning trees (RLT) (Zhu et al., 2015) performance from simu-
lation Scenarios 3 and 4 as visualized in Figure 3, which displays the mean square
prediction error of the estimated carryover compared with the true carryover from
the testing set, or
Pntest
[
δ̂Ai,1(X i)− δAi,1(X i)
]2
.
Despite the potential for a high mean square error, the crossover design still out-
performs parallel design counterparts despite the presence of carryover effects, as
can be seen in Figures 1 and 2.
Appendix B
92% of study participants, (n = 49) were assigned to the HFLS diet according to
crossover GOWL to maximize change in fullness from baseline. To characterize
the subgroup that, on average, experiences a larger increase in patient reported
fullness, Figure 4 displays the distribution of continuous features across the esti-
mated subgroups. Those assigned to the HFLS diet tend to be older with higher
A1c. Because the HSLF group is small (n = 4), two-sample t-tests would not be
appropriate to test for significant differences between groups, and trends observed
17
Figure 3: Boxplots of mean square error for RLT predicted δA1(X) on the testing
set compared with the true carryover.
in Figure 4 should be confirmed in future studies. However, sex (p = 0.1131),
ethnicity (p = 1), and Tanner stage (p = 0.4427) were tested using Fisher’s exact
tests. All tests were non significant at the 0.05 level.
Figure 4 also displays the distribution of continuous features across the esti-
mated subgroups to minimize the change in hunger from baseline. 51% (n = 27) of
participants were assigned to HFLS. Those assigned to HFLS tend to be older, but
differences in other covariates are not apparent. Although the sample in the HSLF
is larger when we consider hunger as the outcome, both samples are still rather
small. For this reason, two-sample t-tests are still not appropriate. Fisher’s exact
tests again did not yield any significant differences in sex (p = 0.5857), ethnicity
(p = 1), or Tanner stage (p = 0.7040).
In conclusion, using crossover GOWL appears to be effective for estimating the
optimal ITR to maximize the change in satiety. Future research should confirm
these subgroups in large sample sizes to better compare differences across features.
If verified, future recommendations for adolescent minorities can be tailored by age
and A1c levels to improve weight loss. Studies on overweight and obese minority
adolescents are still needed to research alternative interventions for those that
18
Figure 4: Distribution of features across the crossover GOWL estimated diet-
outcome subgroups for both fullness and hunger outcomes
report feeling more satiated from the typical Western diet (HSLF).
Appendix C
The following assumptions are made for the theory behind the method proposed
in the main paper.
1. Positivity : P (A1 = a|X = x) ≥ pi0 > 0 with probability 1
2. Conditional Exchangeability : {Y ∗(−1), Y ∗(1)} ⊥ A1|X
3. Consistency : Yk = Y
∗(Ak)− δA1(X)1{k = 2}
4. Outcomes follow the model
Yk = µ(X) + Akc(X) + δA1(X)1{k = 2}+ k,
for periods k = 1, 2.  = (1, 2)
> has a positive definite covariance matrix,
Σ.
5. There exist M0,M1 <∞ such that |Yk| < M0 almost surely, |δA1(X)| < M1
almost surely, and P
(
|δ̂A1(X)| < M1
)
→ 1 as n→∞
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6. P
[
1{sign[R̂] 6= sign[R]}
]
= oP (λn)
Proof of Lemma 1. The optimal ITR is D0 = argmaxD∈D E[Y
∗{D(X)}]. Note
that, under Assumption (4), D0(X) = sign{c(X)}. The expected treatment re-
sponse difference between treating according to D0 and treating opposite to D0
is
E [Y ∗{D0(X)} − Y ∗{−D0(X)}] = E[Y ∗{sign[c(X)]} − Y ∗{−sign[c(X)]}]
= 2|c(X)|
≥ E[Y ∗{D(X)} − Y ∗{−D(X)}],
for all D ∈ D. Thus, the optimal ITR also maximizes the treatment-response
difference, or D0 = argmaxD∈D E[Y
∗{D(X)} − Y ∗{−D(X)}]. Therefore, it can
be seen that
D0 = argmax
D∈D
E [{Y ∗(1)− Y ∗(−1)}D(X)]
= argmax
D∈D
E
[
1{A1 = D(X)}
P (A1|X) [Y1 − Y2 + δA1(X)]
+
1{A1 6= D(X)}
P (A1|X) [Y2 − δA1(X)− Y1]
]
= argmin
D∈D
E
[
Y1 − Y2 + δA1(X)
P (A1|X) 1{A1 6= D(X)}
]
= argmin
D∈D
E
[
R
P (A1|X) 1{A1 6= D(X)}
]
,
where the second equality follows from Assumption (3). This proves the result.
Proof of Theorem 1. This proof follows from Lemma 1 and the results from Lin
(2002). Recall that ψ(u, v) = max{1− sign(u)v, 0}. Minimizing the risk, Rψ(f) is
equivalent to minimizing the conditional risk,
Rψ(f,x) = E
[ |R|
P (A1|X)ψ{R,A1f(X)}
∣∣∣X = x] ,
for every fixed x ∈ X . Let R+ = R1{R ≥ 0} and R− = R1{R < 0}. By the law
of total expectation, the conditional risk becomes
Rψ(f,x) = E
[
|R| ψ{R, f(X)}
∣∣∣X = x, A1 = 1]+ E [|R| ψ{R,−f(X)}∣∣∣X = x, A1 = −1]
= E
[
R+ max{1− f(X), 0} −R−max{1 + f(X), 0}
∣∣∣X = x, A1 = 1]
+ E
[
R+ max{1 + f(X), 0} −R−max{1− f(X), 0}
∣∣∣X = x, A1 = −1] .
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Next, note that Rψ{sign(f),x} < Rψ(f,x) whenever f(x) 6∈ [−1, 1]. For ex-
ample, when f(x) < −1, the conditional risk reduces to
[1− f(x)]
{
E
[
R+
∣∣∣X = x, A1 = 1]− E [R−∣∣∣X = x, A1 = −1]} ,
which is monotonically increasing as f(x) → −∞. A similar argument is made
for when f(x) > 1. Thus, we restrict our search to f(x) ∈ [−1, 1]. Then,
Rψ(f,x) = E
[
R+ −R−
∣∣∣X = x, A1 = 1]+ E [R+ −R−∣∣∣X = x, A1 = −1]
f(X)
{
−E
[
R+ −R−
∣∣∣X = x, A1 = 1]+ E [R+ +R−∣∣∣X = x, A1 = −1]}
= E
[
|R|
∣∣∣X = x, A1 = 1]+ E [|R|∣∣∣X = x, A1 = −1]
+ f(X)
{
E
[
R
∣∣∣X = x, A1 = −1]− E [R∣∣∣X = x, A1 = 1]} .
If f ∗(x) minimizes the conditional risk, then f ∗(x) must have the sign oppo-
site of the expression E
[
R
∣∣∣X = x, A1 = −1] − E [R∣∣∣X = x, A1 = 1], and thus
D0(X) = sign{f ∗(X)}
Proof of Theorem 2. First, define the loss functions
Lψ(f) =
|R|
P (A1|X)ψ{R,A1f(X)}
and
L̂ψ(f) =
∣∣∣R̂∣∣∣
P (A1|X)ψ{R̂, A1f(X)}.
Next, we show that ||f̂ ∗n|| is bounded. For any f ∈ F ,
PnL̂ψ(f̂ ∗n) + λn||f̂ ∗n||2 ≤ PnL̂ψ(f) + λn||f ||2,
by definition of f̂ ∗n. If we choose f = 0, then, for all n large enough,
PnL̂ψ(f̂ ∗n) + λn||f̂ ∗n||2 ≤ PnL̂ψ(0) + λn||0||2
= Pn
{
|R̂i|
P (Ai,1|X i)
}
≤ pi−10 (2M0 +M1),
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where the last inequality holds because of Assumptions (1), (5), and (6). Define
M = pi−10 (2M0 +M1) <∞. Then, because PnL̂ψ(f̂ ∗n) ≥ 0, we have that λn||f̂ ∗n||2 ≤
M.
For any bounded f , such as f̂ ∗n, we may show that
∣∣∣Pn {Lψ(f)− L̂ψ(f)}∣∣∣ =
oP (1) :∣∣∣Pn {Lψ(f)− L̂ψ(f)}∣∣∣ ≤ P ∣∣∣Lψ(f)− L̂ψ(f)∣∣∣+ oP (1)
≤ pi−10 P
∣∣∣|R|ψ{R,A1f(X)} − |R̂|ψ {R̂, A1f(X)}∣∣∣+ oP (1)
≤ pi−10 P
∣∣∣max{|R|, |R̂|} [ψ{R,A1f(X)} − ψ {R̂, A1f(X)}]∣∣∣+ oP (1)
≤ pi−10 (2M0 +M1)P
∣∣∣ψ{R,A1f(X)} − ψ {R̂, A1f(X)}∣∣∣+ oP (1)
≤ 2M(pi0λn)−1(2M0 +M1)P
∣∣∣1{sign[R] 6= sign[R̂]}∣∣∣+ oP (1)
= 2M2λ−1n oP (λn) + oP (1)
= oP (1)
Next, we have
PnLψ(f̂ ∗n) = PnLψ(f̂ ∗n) + PnL̂ψ(f̂ ∗n)− PnL̂ψ(f̂ ∗n)
≤ PnL̂ψ(f̂ ∗n) +
∣∣∣Pn {Lψ(f̂ ∗n)− L̂ψ(f̂ ∗n)}∣∣∣+ λn||f̂ ∗n||2
≤ PnL̂ψ(f ∗) + λn||f ∗||2 +
∣∣∣Pn {Lψ(f̂ ∗n)− L̂ψ(f̂ ∗n)}∣∣∣
≤ PnLψ(f ∗) + λn||f ∗||2 +
∣∣∣Pn {Lψ(f̂ ∗n)− L̂ψ(f̂ ∗n)}∣∣∣+ ∣∣∣Pn {Lψ(f ∗)− L̂ψ(f ∗)}∣∣∣ .
Taking the lim sup on both sides, we find
lim sup
n→∞
PnLψ(f̂ ∗n) ≤ PLψ(f ∗) + oP (λn) ≤ PLψ(f̂ ∗n) + oP (λn)
Thus, it suffices to show that PnLψ(f̂ ∗n) − Pn(Lψ(f̂ ∗n) →P 0. Because λn||f̂ ∗n||2
is bounded by M , {√λnf : ||
√
λnf || ≤
√
M} is contained in a Donsker class.
Note that ψ(u, v) is Lipschitz continuous with respect to v, and, thus, Lψ(f) is
Lipschitz continuous with respect to f . Therefore, {√λnLψ(f) : ||
√
λnf || ≤
√
M}
is also Donsker. This gives us
√
nλn{Pn−P}Lψ(f̂ ∗n) = Op(1), which implies {Pn−
P}Lψ(f̂ ∗n) = oP (1). We finally arrive at
∣∣∣Rψ(f ∗)−Rψ(f̂ ∗n)∣∣∣ = oP (1). Furthermore,
when f ∗0 ∈ F , f ∗0 = f ∗, and∣∣∣R(f̂ ∗n)−R(f0)∣∣∣ ≤ ∣∣∣Rψ(f̂ ∗n)−Rψ(f ∗0 )∣∣∣ = oP (1),
where the first inequality holds from Bartlett et al. (2006).
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